Study Finds XIIDRA May Improve Comfort for Symptomatic Contact Lens Wearers
Thursday, September 11 2025 | 10 h 53 min | News
Results from a new investigator-initiated study suggest that XIIDRA® (lifitegrast ophthalmic solution 5%), a prescription drop approved for dry eye...
Read More
Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye
Tuesday, July 1 2025 | 07 h 26 min | News
Bausch + Lomb Corporation today launched “Eyes Tell the Story: The Impact of Dry Eye” The campaign aims to educate about dry eye through...
Read More
B + L Announces Publication of Phase 4 Data on the Early Effects of MIEBO® on Patient-Reported Outcomes in Dry Eye Disease in Ophthalmology and Therapy Journal
Thursday, March 20 2025 | 14 h 20 min | News
Bausch + Lomb Corporation announced Ophthalmology and Therapy has published results from a phase 4 study which assessed early patient-reported...
Read More
CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions
Wednesday, December 11 2024 | 09 h 24 min | News
The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc have announced the signing of a Memorandum of Understanding (MoU) to...
Read More
Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
Wednesday, July 10 2024 | 11 h 08 min | News
Bausch + Lomb Corporation shared results from the company’s inaugural State of Dry Eye survey, which explores dry eye understanding and...
Read More
